+36.1%
MRNA vs CNP
+49.7%
-13.6%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CNP | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | 0.0% | +5.4% | +5.4% |
| 7D | -1.1% | -1.4% | +0.3% | -1.1% |
| 30D | +126.1% | -2.9% | +129.0% | +126.3% |
| 3M | +190.0% | -7.5% | +197.6% | +192.0% |
| 6M | +157.2% | -7.9% | +165.1% | +158.8% |
| YTD | +388.2% | +3.7% | +384.5% | +378.3% |
| 1Y | +467.0% | +4.6% | +462.4% | +455.1% |
| 3Y | +36.1% | +49.1% | -13.1% | +13.3% |
| All | +36.1% | +49.7% | -13.6% | +13.3% |
Cumulative growth
Daily Returns
Daily percentage return beside CNP.
Daily Out/Under-Performance
Portfolio return minus CNP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CNP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CNP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling